Mineralocorticoid Receptor Antagonism and Aldosterone Synthesis Inhibition Do Not Improve Glomerulosclerosis and Renal Interstitial Fibrosis in a Model of Chronic Kidney Allograft Injury-Reference-Cited by-同舟云学术

Mineralocorticoid Receptor Antagonism and Aldosterone Synthesis Inhibition Do Not Improve Glomerulosclerosis and Renal Interstitial Fibrosis in a Model of Chronic Kidney Allograft Injury

Published:2012 Issue:6 Volume:35 Page:561-567
ISSN:1423-0143
Container-title:Kidney and Blood Pressure Research
language:en
Short-container-title:Kidney Blood Press Res

Author:

Lahmer Tobias,Hermans Rob,Schmaderer Christoph,Chang Jianxing,Stock Konrad,Lutz Jens,Heemann Uwe,Baumann Marcus

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Nephrology,Cardiology and Cardiovascular Medicine,Nephrology

Reference26 articles.

1. Chronic Renal Allograft Dysfunction

2. Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (?CAN?)

3. PATHOLOGIC CLASSIFICATION OF CHRONIC ALLOGRAFT NEPHROPATHY: PATHOGENIC AND PROGNOSTIC IMPLICATIONS1

4. Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy

5. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mineralocorticoid receptor in chronic kidney disease;British Journal of Pharmacology;2021-12-28

2. The m 6 A reader IMP2 directs autoimmune inflammation through an IL-17– and TNFα-dependent C/EBP transcription factor axis;Science Immunology;2021-07-29

3. Vasoactive intestinal peptide infusion reverses existing renal interstitial fibrosis via a blood pressure independent mechanism in the rat;European Journal of Pharmacology;2020-04

4. Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis;Kidney International;2019-08

5. Spironolactone in Post-Transplant Proteinuria: A Safe Alternative Therapy;Transplantation Proceedings;2017-05